Aortic dissection induced by vascular endothelial growth factor inhibitors
Vascular endothelial growth factor (VEGF) contributes to angiogenesis and vasculogenesis. The occurrence and progression of tumors are accompanied by angiogenesis. Vascular endothelial growth factor inhibitors (VEGFI) have been used in anti-tumor treatment. However, aortic dissection (AD) is one of...
Saved in:
Main Authors: | Shuqi Dai (Author), Yu Zhong (Author), Hongxia Cui (Author), Jin Zhao (Author), Su Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection-A pharmacovigilance analysis
by: Michael Dörks, et al.
Published: (2021) -
Nephrotoxicity induced by vascular endothelial growth factor inhibitors
by: Shirinsadat Badri, et al.
Published: (2022) -
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014) -
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
by: Weidemann AK, et al.
Published: (2013) -
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease
by: Sylvain Broussy
Published: (2024)